Show simple item record

Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study

dc.contributor.authorMaggio, Aurelio
dc.contributor.authorMahuzier, Bruyere
dc.contributor.authorGadbaw, Brian
dc.contributor.authorAYDINOK, YEŞİM
dc.contributor.authorKarakas, Zeynep
dc.contributor.authorHollaender, Norbert
dc.contributor.authorRivella, Stefano
dc.contributor.authorTaher, Ali T.
dc.contributor.authorCassinerio, Elena
dc.contributor.authorSiritanaratkul, Noppadol
dc.contributor.authorKattamis, Antonis
dc.date.accessioned2021-03-03T10:48:37Z
dc.date.available2021-03-03T10:48:37Z
dc.date.issued2018
dc.identifier.citationTaher A. T. , Karakas Z., Cassinerio E., Siritanaratkul N., Kattamis A., Maggio A., Rivella S., Hollaender N., Mahuzier B., Gadbaw B., et al., "Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study", BLOOD, cilt.131, sa.2, ss.263-265, 2018
dc.identifier.issn0006-4971
dc.identifier.otherav_24bd8420-9c84-402a-aa59-c347dee78e3e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/29592
dc.identifier.urihttps://doi.org/10.1182/blood-2017-06-790121
dc.language.isoeng
dc.subjectHEMATOLOJİ
dc.subjectHematoloji
dc.subjectTıp
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleEfficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study
dc.typeMakale
dc.relation.journalBLOOD
dc.contributor.departmentAmerican University of Beirut , ,
dc.identifier.volume131
dc.identifier.issue2
dc.identifier.startpage263
dc.identifier.endpage265
dc.contributor.firstauthorID250761


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record